Inventor
Verney L. Sallee
Inventor
Burleson, TX, US
Overview
Patents· 22 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes52%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations21%
C07CAcyclic or carbocyclic compounds21%
C07DHeterocyclic compounds5%
PatentTitleYear
6,723,748'Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension'20046,353,000'11-halo prostaglandins for the treatment of glaucoma or ocular hypertension'20026,353,014'15-ketal postaglandins for the treatment of glaucoma or ocular hypertension'20026,344,478'Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension'20026,197,812'Substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives'20016,184,250'Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension'20016,166,073'Combinations of DP and FP type prostaglandins for lowering IOP'20006,025,392'substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives'20005,889,052'Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension'19995,811,443'Combinations of prostaglandins and clonidine derivatives for the treatment of glaucoma'19985,721,273'Use of certain 9-halo-13,14-dihydroprostaglandins to treat glaucoma and ocular hypertension'19985,705,510'Use of cabergoline and related ergoline derivatives for controlling intraocular pressure'19985,700,835'3-Oxa-D-prostaglandins for lowering IOP'19975,665,773'Cloprostenol and fluprostenol analogues and their use to treat glaucoma and ocular hypertension'19975,627,209'Use of certain 9-haloprostaglandins to treat glaucoma and ocular hypertension'19975,605,922'Combinations of prostaglandins and clonidine derivatives for the treatment of glaucoma'19975,565,492'Prostaglandin combinations in glaucoma therapy'19965,510,383'Use of cloprostenol, fluprostenol and their salts and esters to treat glaucoma and ocular hypertension'19965,480,900'Combinations of prostaglandins and clonidine derivatives for the treatment of glaucoma'19965,173,507'Prostaglandin combinations in glaucoma therapy'19924,822,819'Use of trimoprostil and derivatives in glaucoma therapy'19894,822,820'Use of tri-methyl PG-F.sub.2 a and derivatives in glaucoma therapy'1989Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1989–2002Patents assigned to ALCON LAB INC (19)· patent assignee history
1989–2000Based in Southlake, TX, US· patent location history
1996–2004Based in Burleson, TX, US· patent location history
1999Patents assigned to ALCON LABORATIES INC (1)· patent assignee history
2002–2004Patents assigned to ALCON MFG LTD (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ALCON LAB INC | 19 | 1989–2002 |
| ALCON MFG LTD | 2 | 2002–2004 |
| ALCON LABORATIES INC | 1 | 1999 |
Locations
| Location | Patents | Span |
|---|---|---|
| Burleson, Texas, US | 14 | 1996–2004 |
| Southlake, Texas, US | 8 | 1989–2000 |